Pacs Group announces NYSE listing extension

PACS Group (PACS) announced that on September 9, 2025, the NYSE Listing Operations Committee agreed to provide the company with an additional trading period through November 19, 2025, subject to its ongoing review of the company. The additional trading period provides PACS additional time to complete the previously announced restatement of its financial statements for the three months ended March 31, 2024, and the three and six months ended June 30, 2024 and become current with its SEC filing obligations, which are required for the company to regain compliance with the NYSE listing standards. “We have been fully cooperating with the independent Audit Committee’s ongoing independent investigation and working diligently to restate our prior financial statements and become current with our financial reporting obligations, which we intend to do within the NYSE timeline,” said Jason Murray, PACS’s CEO. “At the same time, we have been executing on our business objectives and delivering on our focused growth strategy. PACS today is benefiting from solid business momentum, and we are in a strong financial and operational position supported by a growing portfolio of high-quality facilities and a solid balance sheet. Over the last year, we have maintained strong employee retention levels in our operations, and our team has remained steadfast in its commitment to our mission of revolutionizing the delivery, leadership, and quality of post-acute care. Based on our progress, when we become current in our SEC filings, we expect to report record revenue and Adjusted EBITDA for the first six months of 20251. We look forward to the Audit Committee completing its investigation as we seek to capitalize on the opportunities ahead to accelerate growth and drive value creation for all stakeholders.”